Drug Target Review: Intravenous immunoglobulins, hyperimmunes and pandemic viruses

David Johnson of GigaGen discusses how recombinant forms of intravenous immunoglobulins (IVIG) could overtake current IVIG therapies and be used in the treatment of COVID-19.

Read the full story.